56,066 trials (keyword fallback)
Deep Vein Thrombosis
Primary: To Provide Estimates of the Specificity of [99mTc] ThromboView® in Patients With Excluded Initial DVT — 76.9; 65.4; 100; 96.2 % Specificity
Diagnostic Errors
Primary: Number of Adolescents Diagnosed With Depression Seen in Well Child Visits — 233; 443 Participants — p=<0.0001
Diagnostic and/or Interventional Radiology Procedures
Primary: Rate of Major Vascular Complications — 0.7 Percentage of Procedures
Pneumonia
Primary: Number of Patients With Modified Diagnosis Probability After Low Dose CT (LDCT) — 10; 3; 4; 34 Participants
Sacroiliac Joint Pain · Sympathetically Maintained Pain
Primary: Pain Score — 2.2; 3.4 units on a scale
Obstructive Sleep Apnea
Primary: Total Length of Desaturation Episodes (ToLDE) Per Patient/Surgical Procedure — 34; 97 minutes
Lung Neoplasms
Primary: Number of Participants With Prevalence of Anaplastic Lymphoma Kinase (ALK) Biomarker — 45; 1346; 21; 38 Participants
Adrenal Insufficiency
Primary: Change From Baseline to Peak Salivary Cortisol Level — 2.9; 4.3; 3.3 Number (ratio of peak to baseline)
Precursor Cell Lymphoblastic Leukemia-Lymphoma · Vitamin D Deficiency
Primary: Change in Serum Vitamin D Level (Group A) — 5.5; -0.30; 1.0; 26.5 ng/ml
Point of Care Ultrasound
Primary: Number of Patients With Change in the Diagnosis After POCUS Examination — 397 Participants
Wrist Arthropathy
Primary: Surgeon-Rated Radiocarpal Visualization With Arthrex Nanoscope — 4.95 score on a scale
Lupus Erythematosus, Systemic
Primary: Relapse-free Complete Clinical Response — 54 Months
Coronary Arterial Disease (CAD)
Primary: 888 Number of Participants With Major Adverse Cardiac Events (MACE) at 30 Days — 0 participants
Radial Artery
Primary: Radial Artery Cross Sectional Area — 3.4; 3.0 mm^2
Malignant Melanoma
Primary: Diagnostic Accuracy to Detect Melanoma — 20; 92; 1; 140 number of skin lesions